| Literature DB >> 24982814 |
Ayano Kutsuma1, Kei Nakajima1, Kaname Suwa2.
Abstract
Skipping breakfast is considered to be an unhealthy eating habit linked to predispositions to obesity and type 2 diabetes. Because eating dinner late at night can elicit subsequent breakfast skipping, we investigated if skipping breakfast concomitant with late-night-dinner eating (LNDE) was associated with metabolic syndrome (MetS) and proteinuria in the general Japanese population. We examined self-reported habitual breakfast skipping and LNDE, MetS (modified ATP-III criteria), and proteinuria in a cross-sectional study of 60,800 Japanese adults aged 20-75 years. A total of 14,068 subjects (23.1%) skipped breakfast, of whom approximately half (52.8%) skipped breakfast alone (without LNDE). The percentages of subjects who skipped breakfast showed a J-shaped relationship with body mass index (BMI). Multivariate logistic regression analysis showed that skipping breakfast concomitant with LNDE (n = 6,645) was significantly associated with MetS and proteinuria, even after adjusting for relevant confounders (odds ratio (95% CI), 1.17 (1.08-1.28), P = 0.0003, and 1.37 (1.24-1.52), P < 0.0001, resp.). Skipping breakfast alone and LNDE alone were not associated with MetS and proteinuria, respectively. In conclusion, habitual breakfast skipping concomitant with LNDE may represent poorer eating behavior than skipping breakfast alone, associated with MetS, asymptomatic proteinuria, obesity, and low body weight in the general Japanese population.Entities:
Year: 2014 PMID: 24982814 PMCID: PMC3984843 DOI: 10.1155/2014/253581
Source DB: PubMed Journal: Scientifica (Cairo) ISSN: 2090-908X
Clinical characteristics of subjects according to four eating behavior groups.
| Eating behavior groups | Normal eating behavior | LNDE alone | Skipping breakfast alone | Skipping breakfast concomitant with LNDE |
|---|---|---|---|---|
|
| 34,971 (57.5) | 11,761 (19.3) | 7,423 (12.2) | 6,645 (10.9) |
| Men, | 20,010 (57.2) | 7,934 (67.5) | 5,174 (69.7) | 5,005 (75.3) |
| Age (years) | 45.2 ± 12.9 | 42.9 ± 12.0 | 39.2 ± 12.0 | 38.5 ± 11.0a,b |
| BMI (kg/m2) | 22.8 ± 3.2 | 23.2 ± 3.4 | 23.0 ± 3.5 | 23.3 ± 3.7b |
| Waist circumference (cm) | 80.2 ± 9.0 | 81.3 ± 9.5 | 80.3 ± 9.6 | 81.4 ± 10.0b |
| Systolic blood pressure (mmHg) | 121 ± 16.4 | 122 ± 16.2 | 121 ± 15.8 | 122 ± 15.8 |
| Diastolic blood pressure (mmHg) | 74 ± 12 | 75 ± 13 | 74 ± 12 | 75 ± 13b |
| Aspartate aminotransferase (IU/L) | 22 (19–26) | 22 (19–27) | 21 (18–25) | 21 (18–26)a,b |
| Alanine aminotransferase (IU/L) | 18 (13–25) | 19 (14–28) | 18 (13–26) | 19 (14–28)b |
|
| 22 (16–36) | 25 (17–43) | 23 (17–37) | 25 (18–43)b |
| Triglycerides (mg/dL) | 90 (61–136) | 91 (61–141) | 90 (61–140) | 91 (60–142) |
| HDL-cholesterol (mg/dL) | 62.6 ± 15.3 | 62.3 ± 15.4 | 60.2 ± 15.1 | 60.7 ± 15.1a |
| HbA1c (%, NGSP) | 5.5 ± 0.6 | 5.5 ± 0.6 | 5.4 ± 0.6 | 5.4 ± 0.6a |
| Past history of CVD, | 450 (1.3) | 159 (1.4) | 85 (1.1) | 67 (1.0) |
| Proteinuria, | 2,009 (5.7) | 741 (6.3) | 623 (8.4) | 568 (8.5) |
| Daily alcohol consumption, | 6,887 (19.7) | 3,761 (32.0) | 1,491 (20.0) | 1,999 (30.1) |
| Current smoker, | 8,611 (24.6) | 3,776 (32.1) | 3,747 (50.5) | 3,574 (53.8) |
| Having regular exercise, | 9,028 (25.8) | 2,741 (23.3) | 1,495 (20.1) | 1,316 (19.8) |
| MetSc, | 4,595 (13.1) | 1,610 (13.7) | 900 (12.1) | 849 (12.8) |
*Bonferroni P < 0.0083, (aLND alone versus skipping breakfast concomitant with LNDE; bskipping breakfast alone versus skipping breakfast concomitant with LNDE).
cMetS was determined according to the modified Adult Treatment Panel III criteria because of the lack of fasting plasma glucose measurement.
Concentrations of hepatic enzymes and triglycerides are expressed as median (interquartile range). Linear trends in clinical parameters across the four eating habit groups were examined by Pearson's correlation coefficient. Hepatic enzymes and triglycerides were log transformed before analysis. All P for trend values in continuous variables were <0.0001. Differences in categorical variables between the four dietary groups were examined by χ 2 tests. All P values were <0.0001, except for past history of CVD (P = 0.16) and MetS (P = 0.02, Cramer V value, 0.01).
BMI: body mass index; CVD: cardiovascular disease (including stroke); HDL: high-density lipoprotein; LNDE: late-night-dinner eating; MetS: metabolic syndrome; NGSP: National Glycohemoglobin Standardization Program.
Figure 1Proportions of subjects who skipped breakfast (SB) and with LNDE (a), and who skipped breakfast concomitant with LNDE (SB + LNDE), according to six body mass index (BMI) categories. The symbols in the middle of each bar represent the mean percentage of subjects with breakfast skipping, LNDE, or breakfast skipping concomitant with LNDE and was calculated as the number of subjects with these behaviors/number of subjects in each BMI group ×100, for each BMI category. The vertical bar represents the standard error (SEM) when skipping breakfast, LNDE, or skipping breakfast concomitant with LNDE was numbered as 1, and the absence of these behaviors as 0. Triangles (▲), circles (●), and diamonds (♦) represent overall breakfast skipping (SB), overall LNDE, and breakfast skipping concomitant with LNDE (SB + LNDE), respectively. The numbers of subjects in each of the six BMI categories from ≤18.9 to ≥27.0 kg/m2 were 5,522, 12,341, 15,708, 12,836, 7,484, and 6,909, respectively. The numbers of subjects in each category who skipped breakfast were 1,316 (9.4%), 2,765 (19.7%), 3,451 (24.5%), 2,862 (20.3%), 1,739 (12.4%), and 1,935 (13.8%); respectively, and the numbers of subjects with LNDE were 1,526 (8.3%), 3,426 (18.6%), 4,550 (24.7%), 3,925 (21.3%), 2,482 (13.5%), and 2,497 (13.6%), respectively. The numbers of subjects with SB + LNDE were 584 (8.8%), 1,256 (18.9%), 1,586 (23.9%), 1,354 (20.4%), 871 (13.1%), and 994 (15.0%), respectively (% of total SB + LNDE).
Odds ratios and 95% CI of unhealthy eating behaviors for MetS, proteinuria, and obesity.
| Normal eating | LNDE alone | Skipping breakfast | Skipping breakfast concomitant with LNDE |
| |
|---|---|---|---|---|---|
| MetS | |||||
| Case | 4,595 | 1,610 | 900 | 849 | |
| Model 1 | 1 (Ref) | 1.05 (0.99–1.11) | 0.91 (0.85–0.98)* | 0.97 (0.90–1.05) | 0.98 (0.96–1.01) |
| Model 2 | 1 (Ref) | 1.14 (1.07–1.22)†† | 1.17 (1.08–1.27)†† | 1.28 (1.18–1.39)†† | 1.09 (1.06–1.11)†† |
| Model 3 | 1 (Ref) | 1.17 (1.10–1.25)†† | 1.08 (1.00–1.17) | 1.21 (1.11–1.32)†† | 1.06 (1.04–1.09)†† |
| Model 3 | |||||
| Men | 1 (Ref) | 1.20 (1.12–1.30)†† | 1.08 (0.99–1.19) | 1.21 (1.10–1.32)†† | 1.06 (1.03–1.09)†† |
| Women | 1 (Ref) | 1.09 (0.96–1.23) | 1.04 (0.88–1.23) | 1.10 (0.91–1.34) | 1.03 (0.98–1.09) |
| Proteinuria | |||||
| Case | 2,009 | 741 | 623 | 568 | |
| Model 1 | 1 (Ref) | 1.10 (1.01–1.20)* | 1.50 (1.37–1.65)†† | 1.53 (1.39–1.69)†† | 1.17 (1.14–1.21)†† |
| Model 2 | 1 (Ref) | 1.08 (0.99–1.18) | 1.43 (1.30–1.57)†† | 1.45 (1.31–1.60)†† | 1.15 (1.11–1.18)†† |
| Model 3 | 1 (Ref) | 1.08 (0.99–1.15) | 1.37 (1.25–1.51)†† | 1.40 (1.26–1.55)†† | 1.13 (1.10–1.17)†† |
| Model 3 | |||||
| Men | 1 (Ref) | 1.09 (0.98–1.22) | 1.40 (1.25–1.58)†† | 1.43 (1.27–1.61)†† | 1.14 (1.10–1.18)†† |
| Women | 1 (Ref) | 1.04 (0.90–1.22) | 1.38 (1.16–1.63)† | 1.41 (1.16–1.71)† | 1.13 (1.07–1.20)†† |
| Obesity | |||||
| Case | 1,038 | 472 | 333 | 360 | |
| Model 1 | 1 (Ref) | 1.37 (1.22–1.53)†† | 1.54 (1.35–1.74)†† | 1.87 (1.66–2.12)†† | 1.23 (1.19–1.28)†† |
| Model 2 | 1 (Ref) | 1.27 (1.14–1.42)†† | 1.31 (1.16–1.49)†† | 1.57 (1.38–1.77)†† | 1.16 (1.11–1.20)†† |
| Model 3 | 1 (Ref) | 1.36 (1.22–1.53)†† | 1.28 (1.13–1.46)† | 1.62 (1.42–1.84)†† | 1.17 (1.12–1.21)†† |
| Model 3 | |||||
| Men | 1 (Ref) | 1.30 (1.14–1.49)† | 1.25 (1.08–1.46)† | 1.53 (1.32–1.77)†† | 1.14 (1.10–1.18)†† |
| Women | 1 (Ref) | 1.53 (1.25–1.88)†† | 1.32 (1.01–1.71)* | 1.89 (1.45–2.46)†† | 1.13 (1.07–1.20)†† |
*P < 0.05, † P < 0.01, †† P < 0.0001.
Model 1: Unadjusted.
Model 2: Adjusted for age and sex.
Model 3: Adjusted for age, sex, current smoking (versus nonsmoking), daily alcohol consumption (versus infrequent/no alcohol consumption), having regular exercise, and past history of cardiovascular disease.
Obesity was defined as body mass index ≥30.0 kg/m2.
Odds ratios and 95% CIs of unhealthy eating behaviors for cardiometabolic conditions.
| Model 1 | Model 2 | Model 3 | Model 4 | |
|---|---|---|---|---|
| LNDE alone | ||||
| (total | ||||
| Current smoking | 1.46 (1.39–1.52)†† | 1.16 (1.10–1.21)†† | 1.15 (1.09–1.21)†† | 1.16 (1.10–1.22)†† |
| Daily alcohol drinking | 2.27 (2.15–2.39)†† | 2.20 (2.08–2.32)†† | 2.23 (2.10–2.36)†† | 2.23 (2.10–2.36)†† |
| Having regular exercise | 0.87 (0.83–0.91)†† | 0.84 (0.80–0.88)†† | 0.85 (0.81–0.89)†† | 0.85 (0.80–0.89)†† |
| Elevated blood pressure | 1.11 (1.06–1.16)†† | 1.07 (1.02–1.12)† | 1.01 (0.96–1.06) | |
| Low HDL-C | 0.83 (0.77–0.91)†† | 0.97 (0.89–1.06) | 0.89 (0.81–0.97)* | |
| High–normal HbA1c | 0.92 (0.87–0.97)† | 1.07 (1.01–1.13)* | 1.02 (0.97–1.08) | |
| Proteinuria | 1.11 (1.02–1.21)* | 1.09 (1.00–1.19)* | 1.08 (0.99–1.18) | 1.06 (0.97–1.16) |
| Continuous BMI | 1.03 (1.03–1.04)†† | |||
| MetS | 1.15 (1.08–1.23)†† | 1.15 (1.08–1.23)†† | ||
| Six BMI categories ( | ||||
| ≤18.9 kg/m2 (4,206) | 0.97 (0.89–1.06) | |||
| 19.0–20.9 kg/m2 (9,576) | 0.95 (0.89–1.02) | |||
| 21.0–22.9 kg/m2 (12,257) | 1 (reference) | |||
| 23.0–24.9 kg/m2 (9,974) | 1.08 (1.01–1.15)* | |||
| 25.0–26.9 kg/m2 (5,745) | 1.21 (1.12–1.30)†† | |||
| ≥27.0 kg/m2 (4,974) | 1.34 (1.24–1.45)†† | |||
| Skipping breakfast alone | ||||
| (total | ||||
| Current smoking | 3.13 (2.98–3.29)†† | 2.88 (2.72–3.04)†† | 2.84 (2.68–3.01)†† | 2.85 (2.69–3.02)†† |
| Daily alcohol drinking | 1.17 (1.10–1.26)†† | 1.03 (0.95–1.11) | 1.03 (0.96–1.11) | 1.03 (0.95–1.11) |
| Having regular exercise | 0.73 (0.69–0.78)†† | 0.73 (0.68–0.78)†† | 0.72 (0.68–0.77)†† | 0.73 (0.68–0.78)†† |
| Elevated blood pressure | 0.96 (0.91–1.01) | 1.12 (1.06–1.19)† | 1.10 (1.03–1.17)† | |
| Low HDL-C | 1.05 (0.95–1.15) | 1.02 (0.92–1.12) | 0.98 (0.89–1.09) | |
| High-normal HbA1c | 0.74 (0.69–0.79) †† | 0.99 (0.92–1.07) | 0.97 (0.90–1.04) | |
| Proteinuria | 1.50 (1.37–1.64) †† | 1.35 (1.23–1.49)†† | 1.35 (1.22–1.49)†† | 1.33 (1.21–1.47)†† |
| Continuous BMI | 1.01 (1.00–1.02)* | |||
| MetS | 1.07 (0.99–1.16) | 1.06 (0.97–1.15) | ||
| Six BMI categories ( | ||||
| ≤18.9 kg/m2 (3,996) | 1.15 (1.04–1.27)† | |||
| 19.0–20.9 kg/m2 (8,915) | 1.05 (0.97–1.14) | |||
| 21.0–22.9 kg/m2 (11,158) | 1 (reference) | |||
| 23.0–24.9 kg/m2 (8,911) | 1.03 (0.95–1.11) | |||
| 25.0–26.9 kg/m2 (5,002) | 1.00 (0.91–1.10) | |||
| ≥27.0 kg/m2 (4,412) | 1.18 (1.07–1.30)† | |||
| Skipping breakfast concomitant with LNDE | ||||
| (total | ||||
| Current smoking | 3.56 (3.38–3.76)†† | 2.79 (2.63–2.96)†† | 2.76 (2.60–2.92)†† | 2.78 (2.62–2.96)†† |
| Daily alcohol drinking | 2.12 (1.98–2.27)†† | 1.90 (1.77–2.05)†† | 1.93 (1.78–2.08)†† | 1.92 (1.78–2.08)†† |
| Having regular exercise | 0.71 (0.67–0.76)†† | 0.69 (0.64–0.74)†† | 0.69 (0.64–0.74)†† | 0.69 (0.65–0.74)†† |
| Elevated blood pressure | 1.05 (1.00–1.11) | 1.16 (1.09–1.23)†† | 1.07 (1.00–1.14) | |
| Low HDL-C | 0.86 (0.77–0.96)† | 0.92 (0.82–1.03) | 0.84 (0.75–0.95)† | |
| High-normal HbA1c | 0.76 (0.71–0.82)†† | 1.10 (1.02–1.19)* | 1.04 (0.96–1.13) | |
| Proteinuria | 1.53 (1.39–1.69)†† | 1.39 (1.25–1.54)†† | 1.37 (1.24–1.52)†† | 1.34 (1.21–1.48)†† |
| Continuous BMI | 1.04 (1.03-1.04)†† | |||
| MetS | 1.19 (1.09–1.29)†† | 1.17 (1.08–1.28)† | ||
| Six BMI categories ( | ||||
| ≤18.9 kg/m2 (3,848) | 1.16 (1.04–1.29)† | |||
| 19.0–20.9 kg/m2 (8,662) | 1.06 (0.97–1.15) | |||
| 21.0–22.9 kg/m2 (10,879) | 1 (reference) | |||
| 23.0–24.9 kg/m2 (8,757) | 1.10 (1.01–1.19)* | |||
| 25.0–26.9 kg/m2 (5,005) | 1.20 (1.09–1.32)† | |||
| ≥27.0 kg/m2 (4,465) | 1.54 (1.40–1.70)†† |
The number of total subjects in each analysis comprises that of normal eating behavior (n = 34,971) plus that of LNDE alone (n = 11,761)a, skipping breakfast alone (n = 7,423)b, or skipping breakfast concomitant with LNDE (n = 6,645)c.
*P < 0.05, † P < 0.01, †† P < 0.0001.
The number of subjects and those with confounding factors in each unhealthy eating behavior group is the same as that in Table 1.
Model 1: Unadjusted.
Model 2: Adjusted for age, sex, current smoking (versus noncurrent smoking), daily alcohol consumption (versus infrequent/no alcohol consumption), having regular exercise (versus nonregular exercise), and past history of cardiovascular disease (versus nonpast history).
Model 3: Adjusted as for Model 2 plus MetS and proteinuria.
Model 4: Adjusted as for Model 2 plus elevated blood pressure, low HDL-C, high-normal HbA1c, BMI categories, and proteinuria.